Topics

Hypha Discovery and Cypex announce a partnership to expand client access to drug metabolites

03:00 EST 3 Feb 2020 | Sciad Newswire

Slough/Dundee, UK, 3rd February 2020 / Sciad NewswireHypha Discovery Limited, the leading specialist CRO for drug metabolite provision, and Cypex Limited, experts in the provision of recombinant xenobiotic metabolising enzymes, have formed a partnership wherein Hypha can scale-up and purify metabolites made by Cypex enzymes (available as Bactosomes​).

Original Article: Hypha Discovery and Cypex announce a partnership to expand client access to drug metabolites

NEXT ARTICLE

More From BioPortfolio on "Hypha Discovery and Cypex announce a partnership to expand client access to drug metabolites"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...